Stem Cells http://www.peprotech.com/
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


First published online January 17, 2008
Stem Cells Vol. 26 No. 2 February 2008, pp. 485 -493
doi:10.1634/stemcells.2007-0252; www.StemCells.com
© 2008 AlphaMed Press

OPEN ACCESS ARTICLE
This Article
Free via Open Access: OA
Right arrow OA Full Text
Right arrow Full Text (PDF)
Right arrow Supplemental Data
Right arrowOA All Versions of this Article:
2007-0252v1
26/2/485    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Reprints/Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by French, A. J.
Right arrow Articles by Wood, S. H.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by French, A. J.
Right arrow Articles by Wood, S. H.

TECHNOLOGY DEVELOPMENT

Development of Human Cloned Blastocysts Following Somatic Cell Nuclear Transfer with Adult Fibroblasts

Andrew J. Frencha, Catharine A. Adamsb, Linda S. Andersonb, John R. Kitchenc, Marcus R. Hughesc, Samuel H. Wooda,b

aStemagen Corporation, La Jolla, California, USA;
bThe Reproductive Sciences Center, La Jolla, California, USA;
cGenesis Genetics Institute, LLC, Detroit, Michigan, USA

Key Words. Egg donation • Nuclear transfer • Human • Embryo • Somatic cell nuclear transfer • Oocytes • Blastocysts

Correspondence: Andrew J. French, Ph.D., Stemagen Corp., 4150 Regents Park Row, La Jolla, California 92037, USA. Telephone: 858-453-2305; Fax: 858-754-1295; e-mail: afrench{at}stemagen.com

Received April 4, 2007; accepted for publication January 3, 2008.
First published online in STEM CELLS EXPRESS   January 17, 2008.



Nuclear transfer stem cells hold considerable promise in the field of regenerative medicine and cell-based drug discovery. In this study, a total of 29 oocytes were obtained from three young (20–24 years old) reproductive egg donors who had been successful in previous cycles. These oocytes, deemed by intended parents to be in excess of their reproductive needs, were donated for research without financial compensation by both the egg donor and intended parents after receiving informed consent. All intended parents successfully achieved ongoing pregnancies with the oocytes retained for reproductive purposes. Mature oocytes, obtained within 2 hours following transvaginal aspiration, were enucleated using one of two methods, extrusion or aspiration, after 45 minutes of incubation in cytochalasin B. Rates of oocyte lysis or degeneration did not differ between the two methods. Somatic cell nuclear transfer (SCNT) embryos were constructed using two established adult male fibroblast lines of normal karyotype. High rates of pronuclear formation (66%), early cleavage (47%), and blastocyst (23%) development were observed following incubation in standard in vitro fertilization culture media. One cloned blastocyst was confirmed by DNA and mitochondrial DNA fingerprinting analyses, and DNA fingerprinting of two other cloned blastocysts indicated that they were also generated by SCNT. Blastocysts were also obtained from a limited number of parthenogenetically activated oocytes. This study demonstrates, for the first time, that SCNT can produce human blastocyst-stage embryos using nuclei obtained from differentiated adult cells and provides new information on methods that may be needed for a higher level of efficiency for human nuclear transfer.

Disclosure of potential conflicts of interest is found at the end of this article.




This article has been cited by other articles:


Home page
Hum ReprodHome page
R. E. Pina-Aguilar
Bringing together clinical embryology and basic reproduction around human cloning
Hum. Reprod., December 1, 2008; 23(12): 2875 - 2876.
[Full Text] [PDF]


Home page
Stem CellsHome page
M. L. Condic and M. Rao
Regulatory Issues for Personalized Pluripotent Cells
Stem Cells, November 1, 2008; 26(11): 2753 - 2758.
[Abstract] [Full Text] [PDF]


Home page
Mol Hum ReprodHome page
B.V. Johnson, N. Shindo, P.D. Rathjen, J. Rathjen, and R.A. Keough
Understanding pluripotency--how embryonic stem cells keep their options open
Mol. Hum. Reprod., September 1, 2008; 14(9): 513 - 520.
[Abstract] [Full Text] [PDF]


Home page
Stem CellsHome page
R. P. Cervera and M. Stojkovic
Commentary: Somatic Cell Nuclear Transfer--Progress and Promise
Stem Cells, February 1, 2008; 26(2): 494 - 495.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
STEM CELLS THE ONCOLOGIST CME ALPHAMED PRESS JOURNALS
Email Content Delivery
Copyright © 2008 by AlphaMed Press.